Discover and read the best of Twitter Threads about #A1c

Most recents (6)

Betting for the next best thing in digital #diabetes technology:

'#AID systems & algorithms are very effective.
Unfortunately, they are used by a minority of ppl who cld benefit from them.'
-Steven Russell

#EASD2022 #dedoc°voices #nothingaboutuswithoutus @dedocORG 1/n
Betting for the next best thing in digital #diabetes technology:

'In addition to the challenges of getting hybrid #AID systems, they still require setups. They still require the user to #carbcount for meals & initiate correction boluses.'
-Steven Russell

#EASD2022 #dedoc 2/n
Betting for the next best thing in digital #diabetes technology:

'The #IletBionicPancreas pivotal trial results will be published by end Sept.' -Steven Russell

✅ Only setup needed: @PwD's weight
✅ No #carbcounting
✅ Fully automated

#EASD2022 #dedoc°voices #BetaBionics 3/n
Read 14 tweets
Are we becoming robots? #AID systems for everyone with #T1D:

'#CGM is the Archimedean point of #diabetes technology. This is when the idea of closing the loop really emerged.'
-Moshe Phillip

#EASD2022 #dedoc°voices #nothingaboutuswithoutus @EASDnews @dedocORG 1/n
Are we becoming robots? #AID systems for everyone with #T1D:

'#CGM opened our eyes to the fact that the data we used to get was very different from the reality #PwD live.'
-Moshe Phillip

So true. Connecting the red dots' never been our reality.

#EASD2022 #dedoc° @dedocORG 2/n
Are we becoming robots? #AID systems for everyone with #T1D:

'I'd like to convince you they are efficient. Automated Insulin Delivery is safe and efficient.'
-Moshe Phillip

#EASD2022 #dedoc°voices #nothingaboutuswithoutus @EASDnews @dedocORG 2/n
Read 6 tweets
1) Welcome to an #accredited #tweetorial on optimizing the use of #SGLT2i in the management of #T2D. This program is accredited for 0.50 🆓credits for #physicians #nurses #physicianassociates #nursepratcitioners #pharmacists by @academiccme! I am @tmodarressi of @HeartDoctorNJ.
2) This program is intended for healthcare professionals and is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company. See archived programs, all by expert authors, still available for credit at cardiometabolic-ce.com.
Read 47 tweets
#ControlIQ Tandem T:slim #closedloop's aim at improving #TIR. To activate Control IQ, are required:
▶️ current weight
▶️ total daily #Insulin
▶️ carb ratio
▶️ ISF
▶️ correction factors
▶️ meal bolus still required

#dedoc° #dedocvoices #EASD2020 @EASDnews #NothingAboutUsWithoutUs Image
36 wk-trial #ControlIQ in teens and adults in 2019:
▶️ #TIR +11% from 61 to 71%
▶️ major #BG improvement at night 2 to 8am
▶️ average #A1c 7% (#PwD witth A1c >6.5% improved too)
▶️ less #hypos
- Dr Marc Breton, University of Virginia

#dedoc° #dedocvoices #EASD2020 @EASDnews Image
#ControlIQ in real life for 6086 users, average age 42yo, for 6 months:
▶️ #TIR 74.9% for 180 days
▶️ consistent improvement in #BG control
- Dr Marc Breton, University of Virginia

#dedoc° #dedocvoices #EASD2020 #EASD @EASDnews #NothingAboutUsWithoutUs Image
Read 5 tweets
#Omnipod #DASH's had a user centric approach for the PDM design. The average #A1c of Omnipod users is 8.1% - Dr Thomas Danne

#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs Image
Omnipod #DASH is coming to Europe, soon in Austria, Belgium, France, Germany, Switzerland. Does that mean it will replace #Omnipod EROS?

#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs

investor.insulet.com/news-releases/…
#Omnipod #DASH a adopté une approche centrée sur l'utilisateur pour la conception du PDM. L' #HbA1c moyenne des utilisateurs d'Omnipod est de 8,1% - Dr Thomas Danne

#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs Image
Read 4 tweets
New strategy to treat #T1D: Simplici-T1 trail ⤵️
"subcutaneous #insulin is not enough" - Dr Carmen Valcare, on the activation of #glucokinase by #TTP399 improving #BG management.
Results: ⬇️ #TIR, #BG control, and #A1c

#dedoc° #dedocvoices #EASD2020 #EASD @EASDnews Image
Nouvelle stratégie pour traiter le #DT1 : Simplici-T1
"L'insuline sous-cutanée n'est pas suffisante" - Dr Carmen Valcare, sur l'activation de la #glucokinase par le #TTP399 améliorant la gestion de la #BG
Résultats : ⬇️#TIR, #glycémie et #Hba1c

#dedoc° #dedocvoices #EASD Image
*Erratum: ⬆️ #TIR & #BG control, ⬇️ #A1c
Read 3 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!